Feedback    Advertise    Reprints    About    Help    Contact   
Upstream Processing Downstream Processing Manufacturing Analytical Facilities
Archive by Issue Archive by Article Type Supplements
CMC Forum
BioProcess International Conference and Exhibition
BioProcess International, Vol. 8, No. 6, June 2010, p. 62
 





IBC's BioProcess International conference and Exhibition has become the largest, most well-respected forum that focuses solely on technical, regulatory, and strategic planning challenges in the manufacture of biotherapeutics. This event is truly the place to gain the latest industry updates, make new contacts and initiate collaborations in biopharmaceutical production. Why? Four comprehensive tracks will update your knowledge in all areas of bioprocessing at one outstanding forum

Managing Manufacturing Networks: Maximize your present and future facilities from experience with biodefense, subcutaneous high dosing, high-titer projects, and many other cutting-edge case studies and strategies.

Product Lifecycle Management: Learn to use design space strategy to leverage flexibility, mitigate variability, and continuously improve your process.

Cell Culture and Upstream Processing: Hear what comes next after titers increase as companies demonstrate approaches to accelerate process development and control costs while improving quality in upstream processing.

Recovery and Purification: Evaluate and explore the latest breakthroughs to debottleneck downstream capabilities with next-generation purification technologies.

Intimate break-out discussions ensure the direction of your career and your company projects: Managing Partners and Contractors (Practical Solutions to the Issues that Arise); Manufacturing (What Will Take Us to the Next Level of Efficiency and Economics?); Smart Flexibility (What Creates the Right Degree of Flexibility and Cost Reduction in Different Phases of Manufacturing); and Development and Manufacturing Strategies for Biosimilars Products.

Roundtable discussion groups will focus on continuous disposable multicolumn chromatography (emerging technology to enable more efficient downstream processing).

“A must-attend annual conference for biopharmaceutical industry” —Jinyou Zhang, PhD (associate VP of process development and manufacturing at Immunomedics, Inc.)

“A key forum for all aspects of biopharmaceutical process development and CMC” —Jens H. Vogel, PhD (global CMC development team leader and head of isolation and purification at Bayer Healthcare)

Keynote Presentations

  • “Regulatory Modernization: FDA's Desired State for Product Quality” by Helen N. Winkle (director of the Office of Pharmaceutical Science at FDA CDER)

  • “The Role of Biosimilars in Driving Innovation in the Biopharmaceutical Industry” by Thomas J. Vanden Boom, PhD (vice president for global biologics R&D at Hospira, Inc.)

  • “Sustainable Commercial Cell Culture Operations” by W. Blair Okita, PhD (senior vice president of manufacturing sciences and technical operations for Genzyme Corporation)

  • “Finding a Home for Process and Product Development” by S. Robert Adamson, PhD (Advance Biotech Consultants; former senior vice president of product and process development at Wyeth Biopharma)

Colocated

  • On 21 and 22 September, choose from four colocated professional development training courses.

  • Attendees also have access to the colocated conference, “Formulation Strategies for Protein Therapeutics” 21–23 September 2010

NEW THIS YEAR

  • Point–Counterpoint Session: Integrating Raw Materials and Suppliers into a Pharmaceutical Quality System

  • Emerging Analytical Requirements and their Impact on Process Development and Manufacturing

  • Rapid Vaccine Development and Production

  • Four comprehensive two-day training courses

  • Site tour: Amgen's BioNext facility (space is limited)

  • Bio-Rad Sponsored Session: Advancements and Case Studies of Hydroxyapatite for Biomanufacturing

Preconference Symposia

On September 20, choose from three preconference symposia:

  • Technology Transfer for Biopharmaceuticals

  • Prevention of Microbial and Viral Contamination of Cell Culture and Fermentation Processes

  • How Much Data Is Enough? The Statistical Approach to Process Validation

Registration Information

IBC has designed three- and four-day conferences package options to fit all your needs. Early registration is encouraged to take advantage of preregistration discounts. Group discounts are also available to groups of three or more attendees from the same company. Complete details can be found online, or call 1-800-309-4078. When registering, mention priority code BPIFEJ.

 
| | Share
The Best of GE Healthcare: Tools for vaccine processes

In vaccine development and manufacturing, GE Healthcare provides a suite of scalable solutions from cell culture through purification to analysis, which offer flexibility and economy, improve purity and secure quality.

Register to download these two NEW application notes:

Microcarriers and disposable bioreactors for MDCK and Vero cell culture
Secure cell propagation with adherent cells at reduced cost and with increased flexibility

DNA removal from influenza virus culture
HTPD and DoE for development and optimization of a chromatography step for the removal of host cell derived genomic DNA


More Travel Tips from the Editor in Chief
Webinars   
Subscribe   
Reprints   
Contact   
About   
Informa plc
©2002 - 2009 BioProcess International
Ph: 508-616-5550